Vanqua Bio
Dr. Zheng is the Director of Medicinal Chemistry at Vanqua. Prior to joining Vanqua, Jianbin worked at Northwestern University with Dr. Dimitri Krainc and Dr. Richard Silverman as a research assistant professor. His work focused on medicinal chemistry efforts of early drug discovery for CNS diseases and study of drug-protein interactions. Previously, Jianbin worked on several drug discovery projects as a principal investigator at the East China University of Science and Technology in Shanghai.
Vanqua Bio
Vanqua Bio is helping usher in a new era of hope for the millions of people living with neurodegenerative diseases. Our unique drug-development approach is designed to overcome longstanding challenges in the neuroscience field by capitalizing on the power of human genetics to identify genes that cause or increase the risk of neurodegenerative disease. We leverage novel, proprietary research tools and in vitro modeling of disease, based on patient-derived neuronal cells, to develop transformative therapies that slow or stop the progression of Parkinson’s disease (PD), Alzheimer’s disease (AD), amyotrophic lateral sclerosis (ALS) and Gaucher disease (GD).